China Dasheng Biotechnology Company
CDBT · OTC
6/30/2023 | 6/30/2022 | 6/30/2008 | 10/31/2007 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $0 | $1,561 | – |
| Short-Term Investments | $118 | $0 | $0 | – |
| Receivables | $0 | $0 | $3,244 | – |
| Inventory | $0 | $0 | $562 | – |
| Other Curr. Assets | $0 | $0 | $3,103 | – |
| Total Curr. Assets | $126 | $0 | $8,471 | – |
| Property Plant & Equip (Net) | $118 | $0 | $1,619 | – |
| Goodwill | $0 | $0 | $0 | – |
| Intangibles | $0 | $0 | $1,532 | – |
| Long-Term Investments | $0 | $0 | $0 | – |
| Tax Assets | $0 | $0 | $0 | – |
| Other NC Assets | $233 | $0 | $8,632 | – |
| Total NC Assets | $351 | $0 | $11,782 | – |
| Other Assets | $0 | $0 | $0 | – |
| Total Assets | $477 | $0 | $20,253 | – |
| Liabilities | – | – | – | – |
| Payables | $46 | $0 | $726 | – |
| Short-Term Debt | $1,029 | $0 | $0 | – |
| Tax Payable | $0 | $0 | $0 | – |
| Deferred Revenue | $40 | $0 | $0 | – |
| Other Curr. Liab. | $576 | $30 | $809 | – |
| Total Curr. Liab. | $1,691 | $30 | $1,535 | – |
| LT Debt | $0 | $0 | $0 | – |
| Deferred Rev, NC | $0 | $0 | $0 | – |
| Deferred Tax Liab, NC | $0 | $0 | $0 | – |
| Other NC Liab. | $0 | $0 | $1,459 | – |
| Total NC Liab. | $0 | $0 | $1,459 | – |
| Other Liabilities | $0 | $0 | $0 | – |
| Cap. Leases | $0 | $0 | $0 | – |
| Total Liabilities | $1,691 | $30 | $2,994 | – |
| Equity | – | – | – | – |
| Pref Stock | $1 | $0 | $0 | – |
| Common Stock | $41 | $41 | $30 | – |
| Retained Earnings | -$1,470 | $0 | $8,010 | – |
| AOCI | $49 | $0 | $3,808 | – |
| Other Equity | $166 | -$71 | $3,846 | – |
| Total Equity | -$1,214 | -$30 | $15,694 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $1,565 | – |
| Total Liab. & Tot. Equity | $477 | $0 | $20,253 | – |
| Net Debt | $1,021 | $0 | -$1,561 | $0 |